buthionine sulfoximine has been researched along with tetrathiomolybdate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anan, Y; Miyayama, T; Ogra, Y | 1 |
| Doñate, F; Fruehauf, JP; Lee, K; Mazar, AP; Trapp, V | 1 |
2 other study(ies) available for buthionine sulfoximine and tetrathiomolybdate
| Article | Year |
|---|---|
Effect of glutathione depletion on removal of copper from LEC rat livers by tetrathiomolybdate.
Topics: Animals; Buthionine Sulfoximine; Chelating Agents; Copper; Enzyme Inhibitors; Glutathione; Hepatolenticular Degeneration; Humans; Liver; Male; Metallothionein; Molybdenum; Oxidation-Reduction; Rats; Rats, Inbred LEC; Rats, Wistar; Time Factors | 2010 |
Redox-related antimelanoma activity of ATN-224.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Disulfiram; Drug Synergism; Enzyme Inhibitors; Glutathione; Humans; Melanins; Melanoma; Molybdenum; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Superoxide Dismutase; Temozolomide | 2009 |